Abstract: The present invention is drawn to mutant interleukin 6, which has the amino acid arginine in position 176, replacing serine in position 176 with wild-type interleukin 6. The mutant interleukin 6 of the present invention has greater biological activity than the wild-type protein. The present invention is further drawn to methods of making mutant interleukin 6, having arginine at position 176 and methods of using the same.
Type:
Grant
Filed:
May 5, 1995
Date of Patent:
October 28, 1997
Assignee:
Instituto di Ricerche di Biologia Molecolare P. Angelett S.P.A.